Illustration of an unlabeled cream tube and jar with red clover
Perimenopause Skin

Estriol Cream for Skin

Topical estriol is a hormone-based treatment discussed for skin aging. Evidence is limited, and no estriol-containing drug is FDA-approved in the U.S. It should not be treated as an ordinary cosmetic or a proven skin-aging treatment.

Published Content updated Medically reviewed

Dermlore editorial standards

Medically reviewed by Dr. Bardov, MD, PhD (dermatology)

What it is

Estriol is an estrogen. Applying a hormone to skin describes a route of administration; it does not guarantee that the hormone remains only in the skin. Absorption and effects depend on the formulation, dose and application area. Evidence about estradiol, vaginal estrogen or systemic menopausal therapy cannot automatically establish the effectiveness or safety of a facial estriol cream.

What the research shows

Small studies and limits of extrapolation: Small topical-estrogen study (PubMed); Estrogen and skin review (PubMed).

A 1996 study compared specific topical estradiol and estriol preparations in 59 preclimacteric women over six months and reported changes in selected skin measures. Collagen biopsies were obtained from 10 participants. These results do not establish that other formulations have the same benefits or establish long-term safety.

Reviews describe interest in topical estrogen but unresolved questions about formulations and safety. Short, small studies cannot establish long-term cancer or clot safety. The available evidence does not justify describing estriol as superior to retinoids or standard moisturizers.

Why this isn’t a skincare-aisle decision

Estriol and compounded-drug status in the U.S.: FDA menopause guidance; FDA compounding guidance.

FDA says there are no FDA-approved drugs containing estriol and that it does not have evidence that estriol-containing drugs are safe and effective or safer than other estrogen products. Compounded drugs are not FDA-approved. These statements do not determine the safety or effect of an individual product; discuss a proposed hormone product with a qualified clinician.

Do not use an online “cosmetic” label as reassurance about a hormone preparation. Discuss any proposed use with a qualified clinician. Medical history, unexplained bleeding, cancer history and clot risk matter to hormone-treatment decisions. Risks established for systemic menopausal therapy should not be assigned unchanged to a particular facial preparation, but uncertain absorption and limited long-term evidence also prevent a claim that it is risk-free.

How it compares to non-hormonal options

Prescription tretinoin versus OTC retinol: Tretinoin trial review (PubMed); AAD retinoid guidance.

Sun protection and moisturizer remain basic skin care. Randomized-trial evidence supports prescription tretinoin for some signs of photoaging; OTC retinol products differ in formulation and should not be assumed equivalent. Retinoids may irritate and are not suitable for everyone. See retinoid use during perimenopause. Insufficient cosmetic improvement is not, by itself, an indication for hormone treatment.

FAQ

Is facial estriol the same as menopausal hormone therapy?

No. Different estrogens, doses, formulations and routes have different evidence. Facial application does not prove absence of systemic exposure.

Can I add estriol to my regular routine?

Ask a qualified clinician about the exact preparation and its purpose. Do not assume that a compounded hormone is a routine cosmetic add-on.

Is topical estriol safe for everyone?

No such assurance is supported. U.S. FDA approval is absent, and long-term safety evidence for facial skin-aging use is limited.

References

  1. Treatment of skin aging with topical estrogens International Journal of Dermatology · 1996
  2. Estrogen and skin: therapeutic options American Journal of Clinical Dermatology · 2011
  3. Menopause U.S. Food and Drug Administration
  4. Compounding and the FDA: Questions and Answers U.S. Food and Drug Administration
  5. Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials International Journal of Women’s Dermatology · 2022
  6. Retinoid or retinol? American Academy of Dermatology

Dermlore provides general educational information, not personal medical advice, diagnosis or treatment. Reading this site does not create a doctor–patient relationship. Consult a qualified healthcare professional for advice about your circumstances. Medical disclaimer.

Related reading